{
  "cik": 1699350,
  "cik_padded": "0001699350",
  "entityName": "SHOULDER INNOVATIONS, INC.",
  "fiscal_years": [
    {
      "accn": "0001699350-26-000011",
      "filed": "2026-03-10",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7408000.0,
        "cash": 26871000.0,
        "cost_of_revenue": 11115000.0,
        "eps_diluted": -4.65,
        "free_cash_flow": -36020000.0,
        "gross_profit": 36202000.0,
        "net_income": -40359000.0,
        "operating_cash_flow": -28612000.0,
        "operating_income": -26297000.0,
        "revenue": 47317000.0,
        "stockholders_equity": 140750000.0,
        "total_assets": 169907000.0,
        "total_liabilities": 29157000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7650949975695839,
        "leverage": 0.20715452930728243,
        "net_margin": -0.8529492571380266,
        "operating_margin": -0.5557621996322675,
        "revenue_growth_yoy": 0.49628434999841886,
        "roa_avg2y": -0.3789808767671266,
        "roa_period_end": -0.2375358284237848,
        "roe_avg2y": -0.9379815234443089,
        "roe_period_end": -0.2867424511545293
      }
    },
    {
      "accn": "0001699350-26-000011",
      "filed": "2026-03-10",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4015000.0,
        "cash": 6123000.0,
        "cost_of_revenue": 7282000.0,
        "eps_diluted": -242.04,
        "free_cash_flow": -18158000.0,
        "gross_profit": 24341000.0,
        "net_income": -15619000.0,
        "operating_cash_flow": -14143000.0,
        "operating_income": -14653000.0,
        "revenue": 31623000.0,
        "stockholders_equity": -54695000.0,
        "total_assets": 43080000.0,
        "total_liabilities": 23300000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7697245675615849,
        "net_margin": -0.49391265850804794,
        "operating_margin": -0.46336527211207035,
        "roa_period_end": -0.36255803156917366,
        "roe_avg2y": 0.3307988817350051
      }
    },
    {
      "accn": "0001699350-26-000011",
      "filed": "2026-03-10",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -39737000.0
      },
      "period_end": "2023-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001699350-26-000011",
    "filed": "2026-03-10",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3841",
  "sic_description": "Surgical & Medical Instruments & Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001699350.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001699350.json"
  },
  "ticker": "SI"
}